OMERACT Hip Inflammation Magnetic Resonance Imaging Scoring System (HIMRISS) Assessment in Longitudinal Study

J Rheumatol. 2019 Sep;46(9):1239-1242. doi: 10.3899/jrheum.181043. Epub 2019 Feb 15.

Abstract

Objective: To assess reliability, feasibility, and responsiveness of Hip Inflammation Magnetic resonance imaging Scoring System (HIMRISS) for bone marrow lesions (BML) in hip osteoarthritis (OA).

Methods: HIMRISS was scored by 8 readers in 360 hips of 90 patients imaged pre/post-hip steroid injection. Pre-scoring, new readers trained online to achieve intraclass correlation coefficient (ICC) > 0.80 versus experts.

Results: HIMRISS reliability was excellent for BML status (ICC 0.83-0.92). Despite small changes post-injection, reliability of BML change scores was high in femur (0.76-0.81) and moderate in acetabulum (0.42-0.56).

Conclusion: HIMRISS should be a priority for further assessment of hip BML in OA, and evaluated for use in other arthropathies.

Keywords: BONE MARROW; HIP JOINT; IMAGING; OMERACT; OSTEOARTHRITIS; SCORING METHODS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Marrow / diagnostic imaging*
  • Hip Joint / diagnostic imaging*
  • Humans
  • Inflammation / diagnostic imaging
  • Magnetic Resonance Imaging*
  • Severity of Illness Index